Literature DB >> 27917596

Plasma adrenocorticotropic hormone but not aldosterone is correlated with blood pressure in patients with aldosterone-producing adenomas.

Hiroki Kobayashi1, Akira Haketa1, Ueno Takahiro1, Hiromasa Otsuka2, Sho Tanaka1, Yoshinari Hatanaka1, Yukihiro Ikeda1, Masanori Abe1, Noboru Fukuda1,3, Masayoshi Soma1,2.   

Abstract

Although plasma aldosterone concentration (PAC) varies depending on primary aldosteronism (PA) subtypes, patients with different subtypes may have similar blood pressure (BP). The authors hypothesized that hormones other than aldosterone might influence BP in PA patients. A total of 73 PA cases, including 30 cases of aldosterone-producing adenomas (APAs), 29 cases of bilateral hyperaldosteronism, and 24 control cases of essential hypertension were enrolled retrospectively. The authors examined the levels of aldosterone, cortisol, renin, and adrenocorticotropic hormone (ACTH) measured at 12 am, 6 am, 12 pm, and 6 pm and BP in the early morning (6 am to 7 am), late morning (9 am to 11 am), and early evening (5 pm to 7 pm). Results showed no statistically significant correlation between PAC and BP in the patients with PA; however, early and late morning systolic BP strongly correlated with ACTH at 6 am in patients with APA. These results suggest that hormones other than aldosterone, such as ACTH, may affect BP in patients with APA. ©2016 Wiley Periodicals, Inc.

Entities:  

Keywords:  zzm321990ACTHzzm321990; aldosterone; blood pressure; primary aldosteronism

Mesh:

Substances:

Year:  2016        PMID: 27917596      PMCID: PMC8030872          DOI: 10.1111/jch.12956

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN: 1524-6175            Impact factor:   3.738


  27 in total

Review 1.  Clinical review 104: Adrenocorticotropin (ACTH)- and non-ACTH-mediated regulation of the adrenal cortex: neural and immune inputs.

Authors:  S R Bornstein; G P Chrousos
Journal:  J Clin Endocrinol Metab       Date:  1999-05       Impact factor: 5.958

2.  Guidelines for the diagnosis and treatment of primary aldosteronism--the Japan Endocrine Society 2009.

Authors:  Tetsuo Nishikawa; Masao Omura; Fumitoshi Satoh; Hirotaka Shibata; Katsutoshi Takahashi; Naohisa Tamura; Akiyo Tanabe
Journal:  Endocr J       Date:  2011-08-09       Impact factor: 2.349

Review 3.  Rapid actions of aldosterone: lymphocytes, vascular smooth muscle and endothelial cells.

Authors:  M Christ; M Wehling
Journal:  Steroids       Date:  1999 Jan-Feb       Impact factor: 2.668

4.  Angiotensin II type 1 receptor and ACTH receptor expression in human adrenocortical neoplasms.

Authors:  B Schubert; M Fassnacht; F Beuschlein; S Zenkert; B Allolio; M Reincke
Journal:  Clin Endocrinol (Oxf)       Date:  2001-05       Impact factor: 3.478

5.  Functional adrenocorticotropic hormone receptor in cultured human vascular endothelial cells : possible role in control of blood pressure.

Authors:  H Hatakeyama; S Inaba; N Taniguchi; I Miyamori
Journal:  Hypertension       Date:  2000-11       Impact factor: 10.190

6.  A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients.

Authors:  Gian Paolo Rossi; Giampaolo Bernini; Chiara Caliumi; Giovambattista Desideri; Bruno Fabris; Claudio Ferri; Chiara Ganzaroli; Gilberta Giacchetti; Claudio Letizia; Mauro Maccario; Francesca Mallamaci; Massimo Mannelli; Mee-Jung Mattarello; Angelica Moretti; Gaetana Palumbo; Gabriele Parenti; Enzo Porteri; Andrea Semplicini; Damiano Rizzoni; Ermanno Rossi; Marco Boscaro; Achille Cesare Pessina; Franco Mantero
Journal:  J Am Coll Cardiol       Date:  2006-11-13       Impact factor: 24.094

Review 7.  The metabolic syndrome in primary aldosteronism.

Authors:  Francesco Fallo; Giovanni Federspil; Franco Veglio; Paolo Mulatero
Journal:  Curr Diab Rep       Date:  2008-02       Impact factor: 4.810

8.  Increased intima-media thickness of the common carotid artery in primary aldosteronism in comparison with essential hypertension.

Authors:  Robert Holaj; Tomás Zelinka; Dan Wichterle; Ondrej Petrák; Branislav Strauch; Jirí Widimský
Journal:  J Hypertens       Date:  2007-07       Impact factor: 4.844

Review 9.  Non-genomic aldosterone action: from the cell membrane to human physiology.

Authors:  Ralf Lösel; Martin Feuring; Martin Wehling
Journal:  J Steroid Biochem Mol Biol       Date:  2002-12       Impact factor: 4.292

10.  Hormones other than aldosterone may contribute to hypertension in 3 different subtypes of primary aldosteronism.

Authors:  Fei Ye; Zheng-Yi Tang; Jing-Cheng Wu; Yang Yang; Xiu-Li Tian; Jia-Jia Huang; Shan-Shan Zhang; Guang Ning
Journal:  J Clin Hypertens (Greenwich)       Date:  2013-02-27       Impact factor: 3.738

View more
  2 in total

1.  Role of adrenocorticotropic hormone in essential hypertension and primary aldosteronism.

Authors:  Decio Armanini; Alessandra Andrisani; Guido Ambrosini; Luciana Bordin; Chiara Sabbadin
Journal:  J Clin Hypertens (Greenwich)       Date:  2016-12-05       Impact factor: 3.738

2.  Plasma adrenocorticotropic hormone but not aldosterone is correlated with blood pressure in patients with aldosterone-producing adenomas.

Authors:  Hiroki Kobayashi; Akira Haketa; Ueno Takahiro; Hiromasa Otsuka; Sho Tanaka; Yoshinari Hatanaka; Yukihiro Ikeda; Masanori Abe; Noboru Fukuda; Masayoshi Soma
Journal:  J Clin Hypertens (Greenwich)       Date:  2016-12-05       Impact factor: 3.738

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.